StackLeaf
← Back to feed
VERIFIEDET Finance·positive

Glenmark gets USFDA nod for expanded use of RYALTRIS nasal spray

AI Summary
  • ·Glenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray.
  • ·The approval expands its use to children aged six to twelve years.
  • ·RYALTRIS treats symptoms of seasonal allergic rhinitis and combines antihistamine and corticosteroid.
GLENMARK
Read original →